GILEAD SCIENCES INC Insider Trading for October 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for October 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 2,000 | 81,120 | 24,240 | |
| Oct 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 110.00 | 2,000 | 220,007 | 32,244 | 34.2 K to 32.2 K (-5.84 %) |
| Oct 28 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 2,000 | 81,120 | 34,244 | 32.2 K to 34.2 K (+6.20 %) |
| Oct 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 14.34 | 15,000 | 215,063 | 51,000 | |
| Oct 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 104.67 | 1,098 | 114,926 | 42,405 | 43.5 K to 42.4 K (-2.52 %) |
| Oct 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 104.03 | 13,902 | 1,446,224 | 43,503 | 57.4 K to 43.5 K (-24.22 %) |
| Oct 23 2014 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 14.34 | 15,000 | 215,063 | 57,405 | 42.4 K to 57.4 K (+35.37 %) |
| Oct 09 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Option Exercise | M | 8.01 | 146,895 | 1,175,894 | 293,718 | |
| Oct 09 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 104.86 | 98,408 | 10,318,571 | 974,048 | 1.1 M to 974 K (-9.18 %) |
| Oct 09 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 104.18 | 44,387 | 4,624,282 | 1,072,456 | 1.1 M to 1.1 M (-3.97 %) |
| Oct 09 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Sell | S | 103.16 | 4,100 | 422,965 | 1,116,843 | 1.1 M to 1.1 M (-0.37 %) |
| Oct 09 2014 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and COO | Buy | M | 8.01 | 146,895 | 1,175,894 | 1,120,943 | 974 K to 1.1 M (+15.08 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Option Exercise | M | 8.01 | 140,625 | 1,125,703 | 281,258 | |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 107.41 | 1,400 | 150,374 | 4,429,387 | 4.4 M to 4.4 M (-0.03 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 106.60 | 29,725 | 3,168,795 | 4,430,787 | 4.5 M to 4.4 M (-0.67 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Sell | S | 105.71 | 109,500 | 11,574,676 | 4,460,512 | 4.6 M to 4.5 M (-2.40 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Chairman and CEO | Buy | M | 8.01 | 140,625 | 1,125,703 | 4,570,012 | 4.4 M to 4.6 M (+3.17 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Option Exercise | M | 23.76 | 31,000 | 736,405 | 73,367 | |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 106.69 | 249 | 26,566 | 120,694 | 120.9 K to 120.7 K (-0.21 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 105.91 | 1,751 | 185,443 | 120,943 | 122.7 K to 120.9 K (-1.43 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 107.47 | 200 | 21,493 | 122,694 | 122.9 K to 122.7 K (-0.16 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 106.59 | 5,395 | 575,042 | 122,894 | 128.3 K to 122.9 K (-4.21 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Sell | S | 105.83 | 25,405 | 2,688,715 | 128,289 | 153.7 K to 128.3 K (-16.53 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP, Corp & Med Af ... | Buy | M | 23.76 | 31,000 | 736,405 | 153,694 | 122.7 K to 153.7 K (+25.27 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Option Exercise | M | 40.56 | 2,000 | 81,120 | 26,240 | |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Sell | S | 106.39 | 2,000 | 212,785 | 32,244 | 34.2 K to 32.2 K (-5.84 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Carter Paul Rutherford | EVP Commercial Ops | Buy | M | 40.56 | 2,000 | 81,120 | 34,244 | 32.2 K to 34.2 K (+6.20 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | M | 26.99 | 5,000 | 134,950 | 25,000 | |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Sell | S | 106.99 | 5,000 | 534,950 | 15,641 | 20.6 K to 15.6 K (-24.22 %) |
| Oct 03 2014 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Buy | M | 26.99 | 5,000 | 134,950 | 20,641 | 15.6 K to 20.6 K (+31.97 %) |